Rhumbline Advisers »

Rapt Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 43k 24.85
2023-09-30 $707k 43k 16.62
2023-06-30 $815k 44k 18.70
2023-03-31 $766k 42k 18.34
2022-12-31 $702k 36k 19.79
2022-09-30 $835k 35k 24.07
2022-06-30 $585k 32k 18.26
2022-03-31 $483k 22k 21.99
2021-12-31 $682k 19k 36.75
2021-09-30 $525k 17k 31.07
2021-06-30 $502k 16k 31.77
2021-03-31 $230k 10k 22.22
2020-12-31 $221k 11k 19.73
2020-09-30 $321k 10k 32.21
2020-06-30 $345k 12k 29.02